Expert US stock analyst coverage consensus and rating distribution analysis to understand market sentiment and Wall Street expectations for specific stocks. We aggregate analyst opinions to provide a consensus view of Wall Street expectations including price targets and ratings. We provide consensus ratings, price target analysis, and analyst sentiment for comprehensive coverage. Understand market expectations with our comprehensive analyst coverage and consensus analysis tools for sentiment investing.
This analysis evaluates Amgen Inc. (NASDAQ: AMGN) following recent analyst adjustments, positive clinical trial results, and its inclusion on Insider Monkey’s 10 Most Undervalued Dow Stocks list. With first-quarter 2026 earnings scheduled for post-market release on April 30, Guggenheim has revised i
Amgen Inc. (AMGN) - Guggenheim Raises Price Target Ahead of Q1 Earnings, Supported by Positive TEPEZZA Phase 3 Data - Hot Market Picks
AMGN - Stock Analysis
3845 Comments
748 Likes
1
Maxyne
Legendary User
2 hours ago
Anyone else trying to understand this?
👍 295
Reply
2
Brina
Power User
5 hours ago
Although indices are relatively flat, volatility remains high, emphasizing the importance of disciplined trading.
👍 228
Reply
3
Amanjit
Active Contributor
1 day ago
Free US stock market platform delivering real-time data, expert insights, and actionable strategies for building a stable and profitable investment portfolio. We believe that every investor deserves access to professional-grade tools and analysis regardless of their experience level.
👍 99
Reply
4
Armar
Loyal User
1 day ago
Effort like this sets new standards.
👍 16
Reply
5
Raef
Trusted Reader
2 days ago
A bit frustrating to see this now.
👍 138
Reply
© 2026 Market Analysis. All data is for informational purposes only.